|
Variables
|
Men
|
Premenopausal women
|
Postmenopausal women
|
|---|
|
n
|
155
|
201
|
120
|
|
Age (years)
|
50.1 ± 10.6
|
42.0 ± 6.8**
|
55.0 ± 4.4**,****
|
|
BMI (kg/m2)
|
22.0 ± 1.8
|
21.5 ± 1.7*
|
21.7 ± 1.8
|
|
W (cm)
|
78.0 (74.0–84.0)
|
72.0 (69.5–77.0)**
|
75.0 (71.0–80.0)**,****
|
|
SBP (mmHg)
|
119.3 (110.0–121.3)
|
110.7 (103.3–120.0)**
|
112.7 (107.7–120.0)*
|
|
DBP (mmHg)
|
74.7 (70.0–79.3)
|
72.0 (66.7–79.2)*
|
71.7 (69.3–78.7)*
|
|
FPG (mmol/L)
|
5.1 ± 0.4
|
5.1 ± 0.4
|
5.1 ± 0.4
|
|
2hPG (mmol/L)
|
5.5 ± 1.1
|
5.7 ± 1.0
|
6.0 ± 1.0**,****
|
|
HbA1c (%)
|
5.4 (5.2–5.6)
|
5.4 (5.1–5.6)
|
5.5 (5.3–5.8)**,****
|
|
FINS (mU/L)
|
5.5 (3.8–7.5)
|
6.4 (4.9–8.8)**
|
6.1 (4.5–7.6)
|
|
HOMA-IR
|
1.2 (0.8–1.7)
|
1.4 (1.1–2.0)**
|
1.4 (1.0–1.7)
|
|
TC (mmol/L)
|
4.34 ± 0.48
|
4.28 ± 0.54
|
4.54 ± 0.43**,****
|
|
TG (mmol/L)
|
0.88 (0.69–1.17)
|
0.79 (0.61–1.00)**
|
0.87 (0.65–1.16)***
|
|
HDL-C (mmol/L)
|
1.40 (1.25–1.61)
|
1.53 (1.37–1.78)**
|
1.62 (1.45–1.79)**
|
|
LDL-C (mmol/L)
|
2.65 ± 0.48
|
2.50 ± 0.46**
|
2.61 ± 0.44***
|
|
CRP (mg/L)
|
0.5 (0.3–0.8)
|
0.3 (0.2–0.7)**
|
0.5 (0.2–0.8)****
|
|
Smoking, n (%)
|
76 (49.0)
|
6 (3.0)**
|
1 (0.8)**
|
|
CVD family history, n (%)
|
45 (29.0)
|
52 (25.9)
|
47 (39.2)***
|
- Data were presented as mean ± standard deviation or median (interquartile range)
-
BMI body mass index, W waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, 2hPG 2-h plasma glucose, HbA1c glycated hemoglobin, FINS fasting insulin, HOMA-IR homoeostasis model assessment-insulin resistance index, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, CRP C-reactive protein, CVD cardiovascular disease
- *P < 0.05; **P < 0.01 vs. men; ***P < 0.05; ****P < 0.01 vs. premenopausal women
